HOUSTON, Aug. 8, 2019 /PRNewswire/ -- MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced today that the United States Patent and Trademark Office has issued US Patent 10,360,349 covering its Precision Medicine Service for use by hospitals, pharmaceutical companies, laboratories, he

CHARLOTTE, N.C., Aug. 8, 2019 /PRNewswire/ -- cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), celebrates the second annual National CBD Day. This day is observed on August 8th and was founded by cbdMD in 2018.

KANSAS CITY, Mo., Aug. 8, 2019 /PRNewswire/ -- CRB is excited to announce the promotion of Joshua Miksch, PE to a team leader role for CRB's Boston office.

SAN FRANCISCO, and HERZLIYA, Israel, Aug. 8, 2019 /PRNewswire/ -- 89Bio Ltd. (89bio), a clinical-stage biopharmaceutical company, today announced that the first patients have been screened in its proof of concept Phase 1b/2a clinical trial evaluating its investigational product candidate, BIO89-100, a glycoPE

TORONTO, Aug. 8, 2019 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, announced today a majority investment in CEFALY Technology SPRL ("CEFALY"), a leading global manufacturer and marketer of neuro-modulating medical devices for the prevention and treatment of migraines. CEFALY is the first investment in

BIRMINGHAM, Ala., Aug. 8, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Baird Global Healthcare Conference in New York City and the Wells Fargo Securities Healthcare Conference in Boston. Both conferences will occur Sept. 4-5,

STOCKHOLM, Aug. 8, 2019 /PRNewswire/ -- The data generated from a unique single sequence on the Siemens Healthineers MRI system and SyMRI software provide quantitative MRI, tissue specific parametric maps (R1, T1, R2, T2 and PD), multiple contrast-weighted images and tissue volumes. This supports a faster scan time while providing more information

LEXINGTON, Mass., Aug. 8, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced today that the FDA has accepted the company's IND filing for AGEN2373, a milestone 

LEXINGTON, Mass., Aug. 8, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1, and cancer vaccines provided corporate updates and reported financial results for the second quarter of 2019.

Record Revenue of $9.4 Million and Adjusted EBITDA of $5.1 Million LAVAL, QC, Aug. 8, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a portfolio o